NuCana Biomed is an oncology focused Biopharma company dedicated to the development and commercialization of new medicines to treat patients with cancer. The ProTide Technology Platform has the potential to transform chemotherapy to targeted therapy. ProTides have been designed to target specific patient populations for whom existing chemotherapy is not likely to be effective. By overcoming the key resistance pathways, ProTides aim to significantly improve the efficacy, broaden the clinical utility, and improve the safety profile of many established anticancer agents.
Location: United Kingdom, Edinburgh

Investors 2

Mentions in press and media 2

11.04.2014NuCana Com...NuCana, an Edinburgh, UK-based...funding S...-finsmes.co...
29.11.2011NuCana Bio...NuCana BioMed, an Edinburgh UK...funding U...-finsmes.co...